{"id":315,"date":"2020-06-02T11:36:00","date_gmt":"2020-06-02T02:36:00","guid":{"rendered":"https:\/\/gucvmed.med.gunma-u.ac.jp\/0_web\/?page_id=315"},"modified":"2020-06-02T11:36:00","modified_gmt":"2020-06-02T02:36:00","slug":"2018%e5%b9%b4%e7%a0%94%e7%a9%b6%e4%bc%9a%e3%83%bb%e8%ac%9b%e6%bc%94%e4%bc%9a","status":"publish","type":"page","link":"https:\/\/gucvmed.med.gunma-u.ac.jp\/?page_id=315","title":{"rendered":"2018\u5e74\u7814\u7a76\u4f1a\u30fb\u8b1b\u6f14\u4f1a"},"content":{"rendered":"<h4>\u7b2c17\u56de\u5317\u95a2\u6771\u5fc3\u8840\u7ba1\u5185\u5206\u6cccResearch Meeting\u30002018.1.12\uff08\u6771\u4eac\uff09<\/h4>\n<p>\u78ef\u3000\u9054\u4e5f\u3001Yogi Umbawaran,Mas Rizky Syamsunaruno\u3001\u5c0f\u677f\u6a4b\u7d00\u901a\u3001\u9808\u6c38\u6d69\u7ae0\u3001\u5009\u6797\u6b63\u5f66\u3001\u677e\u4e95\u5f18\u6a39<br \/>\n\u8ca0\u8377\u5fc3\u7b4b\u306b\u304a\u3051\u308b\u8102\u80aa\u9178\u4ee3\u8b1d\u3068\u30b0\u30eb\u30b3\u30fc\u30b9\u4ee3\u8b1d\u306e\u610f\u7fa9<\/p>\n<h4>\u7b2c\uff13\uff10\u56de\u81e8\u5e8a\u4e0d\u6574\u8108\u7814\u7a76\u4f1a\u30002018.1.13\uff08\u6771\u4eac\uff09<\/h4>\n<p>\u7530\u6751\u5cfb\u592a\u90de\u3001\u91d1\u53e4\u5584\u660e\u3001\u4e2d\u5cf6\u3000\u5fe0\u3001\u5165\u6c5f\u5fe0\u4fe1\u3001\u98ef\u585a\u8cb4\u58eb\u3001\u5009\u6797\u6b63\u5f66<br \/>\n\u5fc3\u623f\u6700\u65e9\u671f\u90e8\u4f4d\u304c\u4e09\u5c16\u5f01\u8f2a8\u6642\u306b\u3042\u308bfast-slow\u623f\u5ba4\u7d50\u7bc0\u30ea\u30a8\u30f3\u30c8\u30ea\u30fc\u6027\u983b\u62cd\u306e\uff11\u4f8b\uff0e <\/p>\n<h4>\u81e8\u5e8a\u533b\u306e\u305f\u3081\u306e\u7d71\u8a08\u30bb\u30df\u30ca\u30fc\uff5e\u8a3a\u7642\u306e\u4e2d\u3067\u51fa\u4f1a\u3046\u7d71\u8a08\u304b\u3089\u7814\u7a76\u8a08\u753b\u307e\u3067\uff5e\u30002018.1.13\u3000\uff08\u524d\u6a4b\uff09<\/h4>\n<p>\u85e4\u7530\u6674\u5eb7<br \/>\n\u30ed\u30b8\u30b9\u30c6\u30a3\u30c3\u30af\u56de\u5e30\u5206\u6790<\/p>\n<h4>\u30a6\u30d7\u30c8\u30e9\u30d3Web\u30ab\u30f3\u30d5\u30a1\u30ec\u30f3\u30b9\u30002018.1.19<\/h4>\n<p>\u9ad8\u9593\u5178\u660e<br \/>\nPAH\u6cbb\u7642\u306b\u304a\u3051\u308b\u30bb\u30ec\u30ad\u30b7\u30d1\u30b0<\/p>\n<h4>\u7b2c3\u56de\u4fe1\u5dde\u4e0d\u6574\u8108\u30b5\u30df\u30c3\u30c8\u30002018.1.20\uff08\u677e\u672c\uff09<\/h4>\n<p>\u91d1\u53e4\u5584\u660e<br \/>\nKaneko-AVNRT\u306e\u3059\u3079\u3066\uff0e<\/p>\n<h4>\u7b2c42\u56de\u7cd6\u5c3f\u75c5\u9023\u7d61\u4f1a\u30002018.1.25\uff08\u6771\u4eac\uff09<\/h4>\n<p>\u5009\u6797\u6b63\u5f66<br \/>\n\u30cf\u30a4\u30ea\u30b9\u30af\u7cd6\u5c3f\u75c5\u60a3\u8005\u3078\u306e\u7a4d\u6975\u7684\u8102\u8cea\u4f4e\u4e0b\u7642\u6cd5\u306e\u610f\u7fa9<\/p>\n<h4>\u7fa4\u99ac\u5faa\u74b0\u5668\u587e\u30002018.1.30<\/h4>\n<p>\u8239\u7530\u7adc\u4e00<br \/>\n\u30d1\u30cd\u30ea\u30b9\u30c8\uff1a2\u6b21\u4e88\u9632\u306b\u304a\u3051\u308b\u8102\u8cea\u4f4e\u4e0b\u7642\u6cd5\u306e\u76ee\u6a19\u7ba1\u7406\u306b\u3064\u3044\u3066<\/p>\n<h4>\u7fa4\u99ac\u5927\u5b66\u4e0d\u6574\u8108\u30ab\u30f3\u30d5\u30a1\u30e9\u30f3\u30b9\u30fc\u7279\u5225\u4f01\u753b\u2015\u30002018.1.31\uff08\u524d\u6a4b\uff09<\/h4>\n<p>\u4e2d\u5cf6\u3000\u5fe0<br \/>\n\u7fa4\u99ac\u5927\u5b66\u306b\u304a\u3051\u308b\u907a\u4f1d\u6027\u4e0d\u6574\u8108\u75c7\u5019\u7fa4\u30fb\u5fc3\u7b4b\u75c7\u306e\u907a\u4f1d\u5b50\u89e3\u6790\u30fb\u6a5f\u80fd\u89e3\u6790\u7814\u7a76<\/p>\n<h4>\u9577\u91ce\u5e02\u6c11\u75c5\u9662PAH\u8b1b\u6f14\u4f1a\u30002018.2.2\uff08\u9577\u91ce\uff09<\/h4>\n<p>\u9ad8\u9593\u5178\u660e<br \/>\n\u8eab\u8fd1\u306b\u6f5c\u3080\u80ba\u52d5\u8108\u6027\u80ba\u9ad8\u8840\u5727\u75c7\u306e\u8a3a\u65ad\u3068\u6cbb\u7642<\/p>\n<h4>PH seminar in Tokyo\u30002018.2.3\uff08\u6771\u4eac\uff09<\/h4>\n<p>\u9ad8\u9593\u5178\u660e<br \/>\n\u4f4e\u9178\u7d20\u8840\u75c7\u306b\u3088\u308a\u6cbb\u7642\u306b\u96e3\u6e0b\u3057\u3066\u3044\u308bPAH\u306e1\u4f8b<\/p>\n<h4>\u7b2c1\u56deCardio Renal Diabetes\u7814\u7a76\u4f1a\u30002018.2.8\uff08\u4e45\u7559\u7c73\uff09<\/h4>\n<p>\u5009\u6797\u6b63\u5f66<br \/>\n\u5fc3\u814e\u75c7\u5019\u7fa4\u306e\u30cb\u30e5\u30fc\u30d1\u30e9\u30c0\u30a4\u30e0<\/p>\n<h4>\u81e8\u5e8a\u533b\u306e\u305f\u3081\u306e\u7d71\u8a08\u30bb\u30df\u30ca\u30fc\uff5e\u8a3a\u7642\u306e\u4e2d\u3067\u51fa\u4f1a\u3046\u7d71\u8a08\u304b\u3089\u7814\u7a76\u8a08\u753b\u307e\u3067\uff5e\u30002018.2.10\u3000\uff08\u524d\u6a4b\uff09<\/h4>\n<p>\u85e4\u7530\u6674\u5eb7<br \/>\n\u50be\u5411\u30b9\u30b3\u30a2\u3000\u7121\u4f5c\u70ba\u5272\u308a\u4ed8\u3051\u304c\u3067\u304d\u306a\u3044\u5834\u5408\u306e\u6bd4\u8f03\u53ef\u80fd\u6027\u306e\u62c5\u4fdd<\/p>\n<h4>\u7b2c241\u56de\u4e00\u822c\u5b9a\u671f\u5065\u5eb7\u8a3a\u65ad\u306b\u304a\u3051\u308b\u80f8\u90e8\u30ec\u30f3\u30c8\u30b2\u30f3\u5199\u771f\u306e\u8aad\u5f71\u8b1b\u5ea7\u30002018.2.15\uff08\u9ad8\u5d0e\uff09<\/h4>\n<p>\u8302\u6728\u3000\u5145<\/p>\n<h4>\u7b2c17\u56de\u7fa4\u99ac\u81e8\u5e8a\u30ab\u30f3\u30d5\u30a1\u30e9\u30f3\u30b9\u30002018.2.16\uff08\u524d\u6a4b\uff09<\/h4>\n<p>\u30c6\u30fc\u30de\u300c\u9759\u8108\u8840\u6813\u585e\u6813\u75c7\u300d<\/p>\n<p>1)\t\u5c0f\u677f\u6a4b\u7d00\u901a<br \/>\n\u30d8\u30d1\u30ea\u30f3\u30ab\u30eb\u30b7\u30a6\u30e0\u5728\u5b85\u76ae\u4e0b\u6ce8\u5c04\u6cbb\u7642\u3092\u884c\u3044\u51fa\u7523\u3057\u305f\u8fd1\u4f4d\u90e8\u6df1\u90e8\u9759\u8108\u8840\u6813\u75c7\u5408\u4f75\u598a\u5a66\u306e3\u4f8b<\/p>\n<p>2)\t\u5927\u5c71\u5584\u662d\u5148\u751f<br \/>\nDPC\u30c7\u30fc\u30bf\u30d9\u30fc\u30b9\u3092\u7528\u3044\u305f\u5faa\u74b0\u5668\u75ab\u5b66\u7814\u7a76<\/p>\n<h4>\u85ac\u5264\u6027\u80ba\u969c\u5bb3\u3092\u8003\u3048\u308b\u4f1a\u30002018.2.19\uff08\u524d\u6a4b\uff09<\/h4>\n<p>\u524d\u91ce\u654f\u5b5d<br \/>\n\u85ac\u5264\u6027\u80ba\u969c\u5bb3\u306e\u8a3a\u65ad\u3068\u30de\u30cd\u30b8\u30e1\u30f3\u30c8<\/p>\n<h4>\u5927\u578b\u8840\u7ba1\u708e\u30bb\u30df\u30ca\u30fcin\u7fa4\u99ac\u30002018.2.20\uff08\u524d\u6a4b\uff09<\/h4>\n<p>\u53cd\u753a\u79c0\u7f8e<br \/>\n\u9ad8\u5b89\u52d5\u8108\u708e\u306b\u4f34\u3046Leriche\u75c7\u5019\u7fa4\u3067\u5fc3\u4e0d\u5168\u5897\u60aa\u3092\u7e70\u308a\u8fd4\u3057\u305f\uff11\u4f8b<\/p>\n<h4>\u7b2c2\u968e\u7fa4\u99ac\u5fc3\u81d3\u6838\u533b\u5b66\u8b1b\u6f14\u4f1a\u30002018.2.23(\u524d\u6a4b\uff09<\/h4>\n<p>\u4f50\u85e4\u4e07\u57fa\u4eba<br \/>\nCTA\/SPECT Fusion\u753b\u50cf\u306b\u3088\u308a\u8cac\u4efb\u75c5\u5909\u304c\u7279\u5b9a\u3055\u308c\u305f\u4e00\u4f8b<\/p>\n<h4>\u795e\u5948\u5ddd\u770c\u547c\u5438\u5668\u75be\u60a3\u30d5\u30a9\u30fc\u30e9\u30e02018\u30002018.2.24(\u6a2a\u6d5c\uff09<\/h4>\n<p>\u9752\u6728\u5eb7\u5f18<br \/>\nCOPD\u8a3a\u7642\u306b\u304a\u3051\u308b\u30c7\u30d0\u30a4\u30b9\u9078\u629e\u3068\u5438\u5165\u652f\u63f4<\/p>\n<h4>\u7b2c12\u56de\u5fc3\u4e0d\u5168\u967d\u5727\u6cbb\u7642\u7814\u7a76\u4f1a\u30002018.2.24\uff08\u6771\u4eac\uff09<\/h4>\n<p>\u9ad8\u9593\u5178\u660e<br \/>\n\u5faa\u74b0\u5668\u75be\u60a3\u7ba1\u7406\u306b\u304a\u3051\u308b\u9060\u9694\u30e2\u30cb\u30bf\u30ea\u30f3\u30b0\u30fcASV\u9060\u9694\u7ba1\u7406\u306e\u53ef\u80fd\u6027\u2015<\/p>\n<h4>\u7b2c13\u56de\u524d\u6a4b\u5730\u533a\u5faa\u74b0\u5668\u5185\u79d1\u30df\u30fc\u30c6\u30a3\u30f3\u30b0\u30002018.2.27\uff08\u524d\u6a4b\uff09<\/h4>\n<p>\u5185\u85e4\u6ecb\u4eba<br \/>\n\u5fc3\u623f\u7d30\u52d5\u306b\u304a\u3051\u308b\u6700\u65b0\u306e\u8a71\u984c<\/p>\n<h4>\u7b2c\uff12\u56de\u6839\u7b39\u30d7\u30e9\u30a4\u30de\u30ea\u30b1\u30a2\u533b\u4f1a\u30002018.2.28\uff08\u9ad8\u5d0e\uff09<\/h4>\n<p>\uff11)\t\u6e05\u6c34\u7f8e\u6d25\u592b<br \/>\n\u814e\u6a5f\u80fd\u4f4e\u4e0b\u4f8b\u306b\u5bfe\u3059\u308bSGLT\uff12\u963b\u5bb3\u85ac\u306e\u5f71\u97ff<\/p>\n<p>\uff12)\t\u5c0f\u677f\u6a4b\u7d00\u901a<br \/>\n\u9759\u8108\u8840\u6813\u585e\u6813\u75c7\u306e\u8a3a\u65ad\u3068\u6cbb\u7642<\/p>\n<h4>\u7b2c\uff14\u56de\u7fa4\u99ac\u5185\u79d1\u6551\u6025\u6cbb\u7642\u7814\u7a76\u4f1a\u3010G-MECC\u30112018.3.5\uff08\u524d\u6a4b\uff09<\/h4>\n<p>\u5c0f\u677f\u6a4b\u7d00\u901a<br \/>\n\u52d5\u8108\u786c\u5316\u306e\u7814\u7a76\u3068\u6cbb\u7642\u306e\u65b0\u305f\u306a\u30b9\u30c6\u30fc\u30b8<\/p>\n<h4>Polyvascular Con\uff46erence\u30002018.3.6\uff08\u524d\u6a4b\uff09<\/h4>\n<p>\u4f50\u85e4\u4e07\u57fa\u4eba<br \/>\n\u5faa\u74b0\u5668\u9818\u57df\u306b\u304a\u3051\u308b\u8840\u6813\u6027\u75c5\u5909\u3068\u6cbb\u7642<\/p>\n<h4>\u6771\u6bdb\u5730\u533aCOPD\u7814\u7a76\u4f1a\u30002018.3.6\uff08\u592a\u7530\uff09<\/h4>\n<p>\uff11)\t\u539f\u3000\u5065\u4e00\u90ce<br \/>\nCOPD\/ACO\u8a3a\u7642\u306eUP-TO-DATE<\/p>\n<p>\uff12)\t\u9752\u6728\u5eb7\u5f18<br \/>\nCOPD\u8a3a\u7642\u306b\u304a\u3051\u308b\u30c7\u30d0\u30a4\u30b9\u9078\u629e\u3068\u5438\u5165\u652f\u63f4<\/p>\n<h4>T2DM Forum in\u3000\u9577\u5ca1\u30002018.3.9\uff08\u9577\u5ca1\uff09<\/h4>\n<p>\u5009\u6797\u6b63\u5f66<br \/>\nSGLT2\u963b\u5bb3\u85ac\u306e\u5fc3\u814e\u75c7\u5019\u7fa4\u3078\u306e\u30d3\u30c3\u30b0\u30a4\u30f3\u30d1\u30af\u30c8<\/p>\n<h4>\u7b2c\uff16\uff15\u56de\u7fa4\u99ac\u770c\u5b66\u6821\u533b\u7814\u7a76\u5927\u4f1a\u30012018.3.10\uff08\u524d\u6a4b\uff09<\/h4>\n<p>\u5b87\u90fd\u6728\u654f\u6d69<br \/>\n\u653e\u8ab2\u5f8c\u3068\u4f11\u65e5\u306e\u904a\u3073\u306b\u3064\u3044\u3066\u306e\u30a2\u30f3\u30b1\u30fc\u30c8\u8abf\u67fb<\/p>\n<h4>T2DM Forum in\u3000BOSO\u30002018.3.12(\u6728\u66f4\u6d25\uff09<\/h4>\n<p>\u5009\u6797\u6b63\u5f66<br \/>\nSGLT2\u963b\u5bb3\u85ac\u306e\u5fc3\u814e\u75c7\u5019\u7fa4\u3078\u306e\u30d3\u30c3\u30b0\u30a4\u30f3\u30d1\u30af\u30c8<\/p>\n<h4>Advanced Anticoagulation Conference\u30002018.3.13\uff08\u524d\u6a4b\uff09<\/h4>\n<p>\uff11)\t\u5185\u85e4\u6ecb\u4eba<br \/>\n\u30ab\u30c6\u30fc\u30c6\u30eb\u30a2\u30d6\u30ec\u30fc\u30b7\u30e7\u30f3\u5468\u8853\u671f\u306e\u6297\u51dd\u56fa\u7642\u6cd5<\/p>\n<p>\uff12)\t\u5e83\u4e95\u77e5\u6b73<br \/>\n\u5fc3\u623f\u7d30\u52d5\u5408\u4f75\u60a3\u8005\u306ePCI\u5f8c\u6297\u8840\u6813\u7642\u6cd5<\/p>\n<h4>\u7fa4\u99ac\u5faa\u74b0\u5668\u75be\u60a3\u30ab\u30f3\u30d5\u30a1\u30e9\u30f3\u30b9\u30002018.3.16\uff08\u524d\u6a4b\uff09<\/h4>\n<p>\uff11\uff09\t\u5ead\u524d\u91ce\u83ca<br \/>\n\u6297\u8840\u6813\u7642\u6cd5\u3092\u884c\u3046\u969b\u306e\u6d88\u5316\u7ba1\u969c\u5bb3\u5bfe\u7b56<\/p>\n<p>\uff12\uff09\t\u571f\u5c4b\u5bdb\u5b50<br \/>\nDCA\u30b5\u30f3\u30d7\u30eb\u306e\u81e8\u5e8a\u7684\u691c\u8a0e<\/p>\n<h4>\u4e09\u56fd\u5ce0PAH\u30ab\u30f3\u30d5\u30a1\u30ec\u30f3\u30b9\u30002018.3.16\uff08\u524d\u6a4b\uff09<\/h4>\n<p>\u53cd\u753a\u79c0\u7f8e<br \/>\n\u7fa4\u99ac\u5927\u5b66\u533b\u5b66\u90e8\u9644\u5c5e\u75c5\u9662\u306b\u304a\u3051\u308bPAH\u6cbb\u7642\u306e\u53d6\u308a\u7d44\u307f<\/p>\n<h4>\u7b2c242\u56de\u4e00\u822c\u5b9a\u671f\u5065\u5eb7\u8a3a\u65ad\u306b\u304a\u3051\u308b\u80f8\u90e8\u30ec\u30f3\u30c8\u30b2\u30f3\u5199\u771f\u306e\u8aad\u5f71\u8b1b\u5ea7\u30002018.3.22\uff08\u9ad8\u5d0e\uff09<\/h4>\n<p>\u8302\u6728\u3000\u5145<\/p>\n<h4>\u85e4\u5ca1\u591a\u91ce\u533b\u5e2b\u4f1a\u5b66\u8853\u8b1b\u6f14\u4f1a\u30002018.3.26(\u85e4\u5ca1\uff09<\/h4>\n<p>\u5009\u6797\u6b63\u5f66<br \/>\n\u9ad8\u30c8\u30ea\u30b0\u30ea\u30bb\u30e9\u30a4\u30c9\u8840\u75c7\u3092\u8a3a\u308b<\/p>\n<h4>\u7b2c54\u56de\u30d8\u30eb\u30b9\u30b1\u30a2\u30bb\u30df\u30ca\u30fc\u3000\uff12\uff10\uff11\uff18.\uff13\uff0e\uff12\uff18\uff08\u9ad8\u5d0e\uff09<\/h4>\n<p>\u592a\u7530\u660c\u6a39<br \/>\n\u5fc3\u623f\u7d30\u52d5\u300d\u3068\u3044\u3046\u4e0d\u6574\u8108\uff5e\u56f0\u308b\u3053\u3068\u3001\u6c17\u3092\u4ed8\u3051\u308b\u4e8b\u3001\u6cbb\u7642\u6cd5\uff5e<\/p>\n<h4>T2DM Forum in toyama\u30002018.3.30(\u5bcc\u5c71\uff09<\/h4>\n<p>\u5009\u6797\u6b63\u5f66<br \/>\nSGLT2\u963b\u5bb3\u85ac\u306e\u5fc3\u814e\u75c7\u5019\u7fa4\u3078\u306e\u30d3\u30c3\u30b0\u30a4\u30f3\u30d1\u30af\u30c8<\/p>\n<h4>\u795e\u6238ASV\u8b1b\u6f14\u4f1a\u30002018.4.7\uff08\u795e\u6238\uff09<\/h4>\n<p>\u9ad8\u9593\u5178\u660e<br \/>\n\u73fe\u72b6\u3067\u3044\u304b\u306bASV\u3092\u7528\u3044\u305f\u5fc3\u4e0d\u5168\u6cbb\u7642\u3092\u304a\u3053\u306a\u3046\u3079\u304d\u306a\u306e\u304b<\/p>\n<h4>\u5e73\u621030\u5e74\u5ea6\u7b2c1\u56de\u9ad8\u5d0e\u5e02\uff08\u80ba\u304c\u3093\u30fb\u7d50\u6838\uff09\u691c\u8a3a\u5f93\u4e8b\u8005\u7814\u4fee\u4f1a\u30002018.4.16\uff08\u9ad8\u5d0e\uff09<\/h4>\n<p>\u8302\u6728\u3000\u5145<br \/>\n\u80ba\u304c\u3093\u691c\u8a3a\u306e\u305f\u3081\u306e\u80f8\u90e8X\u7dda\u5199\u771f\u306e\u8aad\u5f71\u8b1b\u5ea7<\/p>\n<h4>Cardio Diabetes Seminar\uff5e\u5fc3\u8840\u7ba1\u75c5\u3092\u898b\u636e\u3048\u305f\u7cd6\u5c3f\u75c5\u6cbb\u7642\u3092\u8003\u3048\u308b\uff5e2018.4.20\uff08\u524d\u6a4b\uff09<\/h4>\n<p>\u6751\u7530\u3000\u8aa0<br \/>\n\u30b0\u30eb\u30ab\u30b4\u30f3\u3068\u5fc3\u6a5f\u80fd\u306e\u95a2\u9023\u306b\u3064\u3044\u3066<\/p>\n<h4>\u8102\u8cea\u7570\u5e38\u75c7\u306e\u75c5\u614b\u3068\u6cbb\u7642Up to date\u30002018.4.23\uff08\u524d\u6a4b\uff09<\/h4>\n<p>\u78ef\u3000\u9054\u4e5f<br \/>\n\u8ca0\u8377\u5fc3\u7b4b\u306b\u304a\u3051\u308b\u8102\u80aa\u9178\u4ee3\u8b1d\u3068\u30b0\u30eb\u30b3\u30fc\u30b9\u4ee3\u8b1d\u306e\u610f\u7fa9<\/p>\n<h4>\u3084\u307e\u306a\u3057\u91cd\u75c7\u80ba\u9ad8\u8840\u5727\u75c7\u3068\u60a3\u8005\u30b1\u30a2\u3092\u8003\u3048\u308b\u4f1a\u30002018.4.27\uff08\u7532\u5e9c\uff09<\/h4>\n<p>\u9ad8\u9593\u5178\u660e<br \/>\n\u5f53\u9662\u306b\u304a\u3051\u308b\u91cd\u75c7\u80ba\u9ad8\u8840\u5727\u6cbb\u7642\u306e\u53d6\u308a\u7d44\u307f\u201d\u91cd\u75c7\u4f8b\u304b\u3089\u307f\u308b\u5371\u967a\u56e0\u5b50\u306e\u691c\u8a0e\u201c<\/p>\n<h4>\u7b2c30\u56de\u4e21\u6bdb\u4e0d\u6574\u8108\u30bb\u30df\u30ca\u30fc\u30002018.4.28\uff08\u5b87\u90fd\u5bae\uff09<\/h4>\n<p>\u7530\u6751\u5cfb\u592a\u90de\u3001\u91d1\u53e4\u5584\u660e\u3001\u4e2d\u5cf6\u3000\u5fe0\u3001\u98ef\u585a\u8cb4\u58eb\u3001\u5009\u6797\u6b63\u5f66<br \/>\n\u901a\u5e38\u306eslow pathway ablation\u76f4\u5f8c\u306bsuperior slow pathway\u304c\u9855\u5728\u5316\u3057superior type fast-slow AVNRT\u304c\u8a98\u767a\u3055\u308c\u305f\u4e00\u4f8b\uff0e<\/p>\n<h4>\u4e09\u90f7\u5e02\u533b\u5e2b\u4f1a\u5b66\u8853\u8b1b\u6f14\u4f1a\u30002018.5.11\uff08\u4e09\u90f7\uff09<\/h4>\n<p>\u9ad8\u9593\u5178\u660e<br \/>\n\u4e09\u90f7\u5e02\u533b\u5e2b\u4f1a\u5b66\u8853\u8b1b\u6f14\u4f1a<\/p>\n<h4>\u9ad8\u9f62\u8005Total Care Seminar\u30002018.5.15\uff08\u524d\u6a4b\uff09<\/h4>\n<p>\u9ad8\u9593\u5178\u660e<br \/>\n\u9ad8\u9f62\u8005\u306b\u5bfe\u3059\u308b\u8840\u6813\u6cbb\u7642\u6226\u7565<\/p>\n<h4>\u7b2c243\u56de\u4e00\u822c\u5b9a\u671f\u5065\u5eb7\u8a3a\u65ad\u306b\u304a\u3051\u308b\u80f8\u90e8\u30ec\u30f3\u30c8\u30b2\u30f3\u5199\u771f\u306e\u8aad\u5f71\u8b1b\u5ea7\u30002018.5.17\uff08\u9ad8\u5d0e\uff09<\/h4>\n<p>\u8302\u6728\u3000\u5145<\/p>\n<h4>\u7b2c16\u56de\u65e5\u672c\u81e8\u5e8a\u533b\u5b66\u30ea\u30b9\u30af\u30de\u30cd\u30b8\u30e1\u30f3\u30c8\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\u5171\u50ac\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0\u30002018.5.25\uff08\u8c4a\u6d32\uff09<\/h4>\n<p>\u5c0f\u677f\u6a4b\u7d00\u901a<br \/>\nDOAC\u6642\u4ee3\u306e\u9662\u5185\u80ba\u585e\u6813\u4e88\u9632\u30de\u30cb\u30e5\u30a2\u30eb\u306e\u4f5c\u6210\u3068\u5de5\u592b<\/p>\n<h4>\u7b2c9\u56de\u5c71\u5f62\u80ba\u9ad8\u8840\u5727\u75c7\u7814\u7a76\u4f1a\u30002018.5.25\uff08\u5c71\u5f62\uff09<\/h4>\n<p>\u9ad8\u9593\u5178\u660e<br \/>\n\u8eab\u8fd1\u306b\u6f5c\u3080\u80ba\u52d5\u8108\u6027\u9ad8\u8840\u5727\u75c7\u306e\u8a3a\u65ad\u3068\u6cbb\u7642<\/p>\n<h4>\u7b2c48\u56de\u81e8\u5e8a\u5fc3\u81d3\u96fb\u6c17\u751f\u7406\u7814\u7a76\u4f1a\u30002018.5.26\uff08\u6771\u4eac\uff09<\/h4>\n<p>\u7530\u6751\u5cfb\u592a\u90ce\u3001\u91d1\u53e4\u5584\u660e\u3001\u4e2d\u5cf6\u3000\u5fe0\u3001\u98ef\u585a\u8cb4\u58eb\u3001\u5009\u6797\u6b63\u5f66<br \/>\n\u983b\u62cd\u4e2d\u306eHA\u3042\u308b\u3044\u306fAH\u9593\u9694\u306e\u5ef6\u9577\u304c\u56de\u8def\u4e0b\u306e\u9806\u4f1d\u5c0e\u30d6\u30ed\u30c3\u30af\u3068\u95a2\u9023\u3057\u3066\u3044\u305ffast-slow \u623f\u5ba4\u7d50\u7bc0\u30ea\u30a8\u30f3\u30c8\u30ea\u30fc\u6027\u983b\u62cd\u306e\u4e00\u4f8b\uff0e<\/p>\n<h4>2018\u8102\u8cea\u7570\u5e38\u75c7\u6cbb\u7642\u30ab\u30f3\u30d5\u30a1\u30e9\u30f3\u30b9\u30002018.5.28\uff08\u524d\u6a4b\uff09<\/h4>\n<p>\u7b20\u9593\u3000\u5468<br \/>\n\u30a8\u30bc\u30c1\u30df\u30d6\u3068\u30b9\u30bf\u30c1\u30f3\u306e\u4f75\u7528\u7642\u6cd5\u306f\u3001\u5fc3\u7b4b\u6897\u585e\u767a\u75c7\u5f8c\u75c7\u4f8b\u306b\u304a\u3044\u3066\u5fc3\u7b4b\u4fdd\u8b77\u52b9\u679c\u304c\u3042\u308b\u306e\u304b\uff1f\u2015\u5fc3\u81d3\u6838\u533b\u5b66\u7684\u30a2\u30d7\u30ed\u30fc\u30c1\u304b\u3089\u306e\u691c\u8a0e\u2015<\/p>\n<h4>Diabetes Clinical Conference \u30002018.5.30(\u524d\u6a4b\uff09<\/h4>\n<p>\u5009\u6797\u6b63\u5f66<br \/>\nSGLT2\u963b\u5bb3\u85ac\u306e\u5fc3\u814e\u75c7\u5019\u7fa4\u3078\u306e\u30d3\u30c3\u30b0\u30a4\u30f3\u30d1\u30af\u30c8\uff08\u4eee\uff09<\/p>\n<h4>\u7b2c\uff12\uff19\u56de\u5c0f\u91ce\u533b\u5b66\u7814\u7a76\u8ca1\u56e3\u7814\u7a76\u6210\u679c\u767a\u8868\u4f1a\u30fb\u7b2c\uff11\u56de\u65e9\u77f3\u4fee\u8a18\u5ff5\u8cde\u8d08\u5448\u5f0f\u30fb\u8a18\u5ff5\u8b1b\u6f14\u4f1a\u30002018.6.2(\u5927\u962a\uff09<\/h4>\n<p>\u9808\u6c38\u6d69\u7ae0<br \/>\n\u8102\u80aa\u9178\u306e\u8cea\u7684\u5909\u5316\u304c\u3082\u305f\u3089\u3059\u5fc3\u4e0d\u5168\u306e\u767a\u75c7\u30fb\u9032\u5c55\u6a5f\u5e8f\u306e\u89e3\u660e<\/p>\n<h4>\u5fc3\u8840\u7ba1\u5408\u4f75\u75c7\u3092\u8003\u3048\u305f\u7cd6\u5c3f\u75c5\u6cbb\u7642\u306e\u3042\u308a\u65b9\u30002018.6.8\uff08\u5b87\u90fd\u5bae\uff09<\/h4>\n<p>\u5009\u6797\u6b63\u5f66<br \/>\n\u7cd6\u5c3f\u75c5\u306e\u5fc3\u8840\u7ba1\u5408\u4f75\u75c7\u306e\u6210\u56e0\u3068\u4e88\u9632<\/p>\n<h4>\u95a2\u6771\u7532\u4fe1\u8d8aPAH\u30bb\u30df\u30ca\u30fc\u30002018.6.9\uff08\u6771\u4eac\uff09<\/h4>\n<p>\u9ad8\u9593\u5178\u660e<br \/>\n\u7279\u767a\u6027\u80ba\u52d5\u8108\u6027\u80ba\u9ad8\u8840\u5727\u75c7\u306b\u5bfe\u3057\u3066\u30ea\u30aa\u30b7\u30b0\u30a2\u30c8\u3092\u7528\u3044\u305f\u75c7\u4f8b\u306e\u9577\u671f\u7d4c\u904e\u5831\u544a<\/p>\n<h4>G GIRLS\u30002018.6.11\uff08\u524d\u6a4b\uff09<\/h4>\n<p>\u53cd\u753a\u79c0\u7f8e<br \/>\n\u5973\u6027\u306b\u304a\u3051\u308b\u5faa\u74b0\u5668\u75be\u60a3\u306b\u3064\u3044\u3066\uff5eHFpEF\u3092\u4e2d\u5fc3\u3068\u3057\u305f\u691c\u8a0e\uff5e\u300d<\/p>\n<h4>Research PlaNet\u30002018\u30002018.6.16-17\uff08\u6771\u4eac\uff09<\/h4>\n<p>\u78ef\u3000\u9054\u4e5f<br \/>\n\u8ca0\u8377\u5fc3\u7b4b\u306b\u304a\u3051\u308b\u8102\u80aa\u9178\u4ee3\u8b1d\u30fb\u30b0\u30eb\u30b3\u30fc\u30b9\u4ee3\u8b1d\u306e\u610f\u7fa9<\/p>\n<h4>-\u6025\u6027\u30fb\u6162\u6027\u5fc3\u4e0d\u5168\u8a3a\u7642\u30ac\u30a4\u30c9\u30e9\u30a4\u30f3\u6539\u8a02-\u5fc3\u4e0d\u5168\u8a3a\u7642\u3092\u8003\u3048\u308b\u4f1a\uff5e\u6025\u6027\u671f\u304b\u3089\u6162\u6027\u671f\u306e\u53d6\u308a\u7d44\u307f\uff5e\u30002018.6.18\uff08\u9ad8\u5d0e\uff09<\/h4>\n<p>\u6afb\u4e95\u7e41\u6a39<br \/>\n\u5fc3\u81d3\u30ea\u30cf\u30d3\u30ea\u30c6\u30fc\u30b7\u30e7\u30f3\u306b\u3088\u308b\u5fc3\u4e0d\u5168\u7ba1\u7406<\/p>\n<h4>\u5b66\u8853\u8b1b\u6f14\u4f1a\u30002018.6.18\uff08\u67cf\u5d0e\uff09<\/h4>\n<p>\u9ad8\u9593\u5178\u660e<br \/>\n\u9759\u8108\u8840\u6813\u585e\u6813\u75c7\u306e\u8a3a\u65ad\u3068\u6cbb\u7642<\/p>\n<h4>\u6e0b\u5ddd\u533b\u7642\u30bb\u30f3\u30bf\u30fc\u85ac\u85ac\u9023\u643a\u7814\u4fee\u4f1a\u30002018.6.21\uff08\u6e0b\u5ddd\uff09<\/h4>\n<p>\u9ad8\u9593\u5178\u660e<br \/>\n\u9759\u8108\u8840\u6813\u585e\u6813\u75c7UPtoDATE~Cancer VTE\u3082\u8e0f\u307e\u3048\u305f\u6700\u5584\u306e\u6cbb\u7642\u3068\u306f~<\/p>\n<h4>Total Management of Atrial Fibrillation\u30002018.6.21\uff08\u9ad8\u5d0e\uff09<\/h4>\n<p>\u592a\u7530\u660c\u6a39<br \/>\n\u5fc3\u4e0d\u5168\u3068\u5fc3\u623f\u7d30\u52d5<\/p>\n<h4>\u5357\u623f\u7dcf\u5faa\u74b0\u5668\u30bb\u30df\u30ca\u30fc\u30002018.6.22\uff08\u9d28\u5ddd\uff09<\/h4>\n<p>\u5009\u6797\u6b63\u5f66<br \/>\n\u52d5\u8108\u786c\u5316\u6027\u75be\u60a3\u4e88\u9632\u306e\u65b0\u3057\u3044\u5c55\u958b<\/p>\n<h4>PH seminar in Osaka\u30002018.6.24\uff08\u5927\u962a\uff09<\/h4>\n<p>\u9ad8\u9593\u5178\u660e<br \/>\nA case of ASD-ES undergone radical surgery with epoprostenol treatment<\/p>\n<h4>\u677e\u5742\u4e2d\u592e\u7dcf\u5408\u75c5\u9662\u5faa\u74b0\u5668\u52c9\u5f37\u4f1a\u30002018.6.26\uff08\u677e\u5742\uff09<\/h4>\n<p>\u9ad8\u9593\u5178\u660e<br \/>\n\u73fe\u72b6\u3067\u3044\u304b\u306bASV\u3092\u7528\u3044\u305f\u5fc3\u4e0d\u5168\u6cbb\u7642\u3092\u304a\u3053\u306a\u3046\u3079\u304d\u306a\u306e\u304b<\/p>\n<h4>\u7b2c244\u56de\u4e00\u822c\u5b9a\u671f\u5065\u5eb7\u8a3a\u65ad\u306b\u304a\u3051\u308b\u80f8\u90e8\u30ec\u30f3\u30c8\u30b2\u30f3\u5199\u771f\u306e\u8aad\u5f71\u8b1b\u5ea7\u30002018.6.28\uff08\u9ad8\u5d0e\uff09<\/h4>\n<p>\u8302\u6728\u3000\u5145<\/p>\n<h4>\u7b2c5\u56de\u7fa4\u99ac\u6210\u4eba\u5148\u5929\u6027\u5fc3\u75be\u60a3\u7814\u7a76\u4f1a\u30002018.6.29\uff08\u524d\u6a4b\uff09<\/h4>\n<p>\u53cd\u753a\u79c0\u7f8e<br \/>\n\u5e7c\u5c11\u671f\u306bEisenmenger\u75c7\u5019\u7fa4\u3068\u8a3a\u65ad\u3055\u308c\u305f\u304c\u3001Treat and Repair\u3092\u8a66\u307f\u3066\u3044\u308bVSD\u306e\u6210\u4eba\u4f8b<\/p>\n<h4>\u897f\u543e\u59bb\u5730\u533a\u8b1b\u6f14\u4f1a\u30002018.7.6\uff08\u8349\u6d25\uff09<\/h4>\n<p>\u9ad8\u9593\u5178\u660e<br \/>\n\u9759\u8108\u8840\u6813\u585e\u6813\u75c7UPtoDATE~Cancer VTE\u3082\u8e0f\u307e\u3048\u305f\u6700\u5584\u306e\u6cbb\u7642\u3068\u306f~<\/p>\n<h4>GLACTIV Expert Meeting2018\u30002018.7.10\uff08\u524d\u6a4b\uff09<\/h4>\n<p>\u6e05\u6c34\u5cb3\u4e45<br \/>\n\u6025\u6027\u5fc3\u7b4b\u6897\u585e\u5f8c\u306b\u3046\u3063\u8840\u6027\u5fc3\u4e0d\u5168\u3092\u5408\u4f75\u3057\u305f\uff12\u578b\u7cd6\u5c3f\u75c5\u60a3\u8005\u306b\u5bfe\u3059\u308b\u30b7\u30bf\u30b0\u30ea\u30d7\u30c1\u30f3\u306e\u4f7f\u7528\u7d4c\u9a13<\/p>\n<h4>WEB\u30ab\u30f3\u30d5\u30a1\u30ec\u30f3\u30b9\u30002018.7.18<\/h4>\n<p>\u5c0f\u677f\u6a4b\u7d00\u901a<br \/>\n\u9759\u8108\u8840\u6813\u585e\u6813\u75c7\u6cbb\u7642\u306b\u304a\u3051\u308b\u521d\u671f\u5f37\u5316\u7642\u6cd5\u306e\u30a4\u30f3\u30d1\u30af\u30c8<\/p>\n<h4>\u7a7a\u77e5\u533b\u5e2b\u4f1a\u8102\u8cea\u7570\u5e38\u75c7\u5b66\u8853\u8b1b\u6f14\u4f1a\u30002018.7.12\uff08\u5317\u6d77\u9053\uff09<\/h4>\n<p>\u5009\u6797\u6b63\u5f66<br \/>\n\u52d5\u8108\u786c\u5316\u6027\u75be\u60a3\u4e88\u9632\u306e\u65b0\u3057\u3044\u5c55\u958b<\/p>\n<h4>\u7b2c33\u56de\u55ab\u7159\u79d1\u5b66\u7814\u7a76\u8ca1\u56e3\u5e73\u621029\u5e74\u5ea6\u52a9\u6210\u7814\u7a76\u767a\u8868\u4f1a\u30002018.7.24\uff08\u6771\u4eac\uff09<\/h4>\n<p>\u9808\u6c38\u6d69\u7ae0<br \/>\n\u55ab\u7159\u306b\u3088\u308b\u8102\u80aa\u9178\u7d44\u6210\u306e\u5909\u5316\u304c\u6162\u6027\u9589\u585e\u6027\u80ba\u75be\u60a3\uff08COPD\uff09\u306e\u767a\u75c7\u30fb\u9032\u5c55\u306b\u53ca\u307c\u3059\u75c5\u614b\u6a5f\u5e8f\u306e\u89e3\u660e<\/p>\n<h4>\u4f0a\u52e2\u5d0e\u4f50\u6ce2\u533b\u5e2b\u4f1a\u5b66\u8853\u8b1b\u6f14\u4f1a\u30002018.7.25\uff08\u4f0a\u52e2\u5d0e\uff09<\/h4>\n<p>\u9ad8\u9593\u5178\u660e<br \/>\nSAS\u8a3a\u7642\u306b\u304a\u3051\u308b\u30d7\u30e9\u30a4\u30de\u30ea\u30fc\u533b\u306e\u5f79\u5272<\/p>\n<h4>Lipid Fourum in\u3000\u753a\u7530\u30002016.7.26\uff08\u6771\u4eac\uff09<\/h4>\n<p>\u5009\u6797\u6b63\u5f66<br \/>\n\u8102\u8cea\u7570\u5e38\u75c7\u6cbb\u7642\u306b\u969b\u3057\u3066\u306e\u7591\u554f<\/p>\n<h4>\u7b2c245\u56de\u4e00\u822c\u5b9a\u671f\u5065\u5eb7\u8a3a\u65ad\u306b\u304a\u3051\u308b\u80f8\u90e8\u30ec\u30f3\u30c8\u30b2\u30f3\u5199\u771f\u306e\u8aad\u5f71\u8b1b\u5ea7\u30002018.7.26\uff08\u9ad8\u5d0e\uff09<\/h4>\n<p>\u8302\u6728\u3000\u5145<\/p>\n<h4>\u7fa4\u99ac\u5fc3\u81d3\u30ab\u30f3\u30d5\u30a1\u30e9\u30f3\u30b9\u30002018.7.30(\u524d\u6a4b\uff09<\/h4>\n<p>\u9ed2\u6ca2\u5e78\u55e3<br \/>\n\u5faa\u74b0\u5668\u5185\u79d1\u304b\u3089\u898b\u305f\u5f01\u819c\u75c7<\/p>\n<h4>\u9ad8\u5d0e\u533b\u5e2b\u4f1a\u5b66\u8853\u8b1b\u6f14\u4f1a\u30002018.7.31\uff08\u9ad8\u5d0e\uff09<\/h4>\n<p>\u9ad8\u9593\u5178\u660e<br \/>\n\u8eab\u8fd1\u306b\u6f5c\u3080\u80ba\u52d5\u8108\u6027\u80ba\u9ad8\u8840\u5727\u75c7\u306e\u8a3a\u65ad\u3068\u6cbb\u7642<\/p>\n<h4>\u7b2c11\u56de\u7fa4\u99ac\u5fc3\u4e0d\u5168\u3068Vasopressin\u8b1b\u6f14\u4f1a\u30002018.8.31\uff08\u524d\u6a4b\uff09<\/h4>\n<p>\u767d\u5009\u6bc5\u4eba<br \/>\n\u5f53\u9662\u3067\u306e\u9ad8\u9f62\u5fc3\u4e0d\u5168\u6cbb\u7642\u3064\u3044\u3066<\/p>\n<h4>\u80ba\u9ad8\u8840\u5727\u75c7\u8a3a\u7642\u306e\u30c8\u30fc\u30bf\u30eb\u30de\u30cd\u30fc\u30b8\u30e1\u30f3\u30c8\u3092\u8003\u3048\u308b\u4f1a\u30002018.9.1\uff08\u6771\u4eac\uff09<\/h4>\n<p>\u9ad8\u9593\u5178\u660e<br \/>\n\u91cd\u75c7IPAH,\u5408\u4f75\u75c7\u306e\u3042\u308bPAH\u3078\u306eTriple combination therapy\u306e\u7d4c\u9a13<\/p>\n<h4>\u5e73\u621030\u5e74\u5ea6\u7fa4\u99ac\u770c\u6307\u5b9a\u96e3\u75c5\u7814\u4fee\u4f1a\u30002018.9.2\uff08\u524d\u6a4b\uff09<\/h4>\n<p>\u9ad8\u9593\u5178\u660e<br \/>\n\u96e3\u75c5\u6307\u5b9a\u306b\u304a\u3051\u308b\u5faa\u74b0\u5668\u30fb\u547c\u5438\u5668\u7cfb\u9818\u57df\u306b\u95a2\u3059\u308b\u4ee3\u8868\u7684\u306a\u75be\u60a3\u306e\u8a3a\u65ad<\/p>\n<h4>\u7b2c20\u56de\u9999\u5ddd\u7761\u7720\u547c\u5438\u969c\u5bb3\u7814\u7a76\u4f1a\u30002018.9.8\uff08\u9ad8\u677e\uff09<\/h4>\n<p>\u9ad8\u9593\u5178\u660e<br \/>\n\u73fe\u72b6\u3067\u3044\u304b\u306bASV\u3092\u7528\u3044\u305f\u5fc3\u4e0d\u5168\u6cbb\u7642\u3092\u304a\u3053\u306a\u3046\u3079\u304d\u306a\u306e\u304b<\/p>\n<h4>Immuno Oncology Forum in\u3000\u7fa4\u99ac\u30002018.9.7\uff08\u9ad8\u5d0e\uff09<\/h4>\n<p>\u5317\u539f\u4fe1\u4ecb<br \/>\nPD-L1\u691c\u67fb\u306b\u57fa\u3065\u304f\u80ba\u764c\u6cbb\u7642\u306e\u73fe\u72b6<\/p>\n<h4>\u7b2c246\u56de\u4e00\u822c\u5b9a\u671f\u5065\u5eb7\u8a3a\u65ad\u306b\u304a\u3051\u308b\u80f8\u90e8\u30ec\u30f3\u30c8\u30b2\u30f3\u5199\u771f\u306e\u8aad\u5f71\u8b1b\u5ea7\u30002018.9.13\uff08\u9ad8\u5d0e\uff09<\/h4>\n<p>\u8302\u6728\u3000\u5145<br \/>\n\u3058\u3093\u80ba\u306e\u8a3a\u65ad\u3000(\u30a2\u30b9\u30d9\u30b9\u30c8\u95a2\u9023\u75be\u60a3\u3092\u542b\u3080)<\/p>\n<h4>\u90e1\u5c71\u5730\u533a\u5faa\u74b0\u5668\u75be\u60a3\u5b66\u8853\u8b1b\u6f14\u4f1a\u30002018.9.14\uff08\u90e1\u5c71\uff09<\/h4>\n<p>\u5009\u6797\u6b63\u5f66<br \/>\n\u5fc3\u8840\u7ba1\u7cfb\u30a4\u30d9\u30f3\u30c8\u6291\u5236\u3092\u8003\u616e\u3057\u305f\u751f\u6d3b\u7fd2\u6163\u75c5\u306e\u6cbb\u7642\u6226\u7565<\/p>\n<h4>Catheter Ablation Seminar\u30002018.9.15\uff08\u5927\u962a\uff09<\/h4>\n<p>\u91d1\u53e4\u5584\u660e\uff1a<br \/>\nsuperior type fast-slow AVNRT\u306e\u7279\u7570\u306a\u96fb\u6c17\u751f\u7406\u5b66\u7684\u7279\u6027\uff0e<\/p>\n<h4>Onco-Cardiology Gunma\u7fa4\u99ac\u816b\u760d\u5faa\u74b0\u5668\u7814\u7a76\u4f1a\u30002018.9.18\uff08\u524d\u6a4b\uff09<\/h4>\n<p>1)\t\u4e2d\u91ce\u8003\u82f1<br \/>\n\u76f4\u63a5\u7d4c\u53e3\u6297\u51dd\u56fa\u85ac\u306e\u5185\u670d\u5316\u3067\u767a\u75c7\u3057\u305f\u975e\u7d30\u83cc\u6027\u8840\u6813\u6027\u5fc3\u5185\u819c\u708e\u306b\u3064\u3044\u3066<\/p>\n<p>2)\t\u5c0f\u677f\u6a4b\u7d00\u901a<br \/>\nCAT\u306b\u3064\u3044\u3066<\/p>\n<p>3)\t\u6839\u5cb8\u4e00\u660e<br \/>\nOnco-Cardiology\u304c\u3093\u306e\u5fc3\u5408\u4f75\u75c7\u306b\u3064\u3044\u3066\u3001\u77e5\u3063\u3066\u304a\u304f\u3079\u304d\u3053\u3068\u306f\u4f55\u304b<\/p>\n<h4>\u7b2c21\u56de\u7fa4\u99ac\u5fc3\u4e0d\u5168\u7814\u7a76\u4f1a\u30002018.9.25\uff08\u524d\u6a4b\uff09<\/h4>\n<p>\u5929\u5185\u58eb\u90ce<br \/>\nSGLT2\u963b\u5bb3\u85ac\u306fpeak oxegen uptake\u3092\u512a\u4f4d\u306b\u5897\u5927\u3055\u305b\u308b\uff5e\u5185\u670d\u524d\u5f8c\u306e\u5fc3\u914d\u904b\u52d5\u8ca0\u8377\u8a66\u9a13\uff08CPX\uff09\u30d1\u30e9\u30e1\u30fc\u30bf\u6bd4\u8f03\u304b\u3089\u306e\u77e5\u898b\uff5e<\/p>\n<h4>ONE Forum@Gunma\u30002018.9.27(\u524d\u6a4b\uff09<\/h4>\n<p>\u75c7\u4f8b\u63d0\u793a<br \/>\n\u8239\u7530\u7adc\u4e00<br \/>\n\u6a0b\u53e3\u4eac\u4ecb<\/p>\n<h4>\u30b9\u30c8\u30e9\u30af\u30c1\u30e3\u30fc\u30af\u30e9\u30d6\u30b8\u30e3\u30d1\u30f3\u3000\u30e9\u30a4\u30d6\u30c7\u30e2\u30f3\u30b9\u30c8\u30ec\u30fc\u30b7\u30e7\u30f32018\u30002018.9.29\uff08\u5ca1\u5c71\uff09<\/h4>\n<p>\u5409\u7530\u304f\u306b\u5b50<br \/>\n\u5de6\u623f\u30b9\u30c8\u30ec\u30a4\u30f3\u2015\u5de6\u5fc3\u8033\u6a5f\u80fd\u3068\u30a8\u30b3\u30fc\u3067\u3069\u3053\u307e\u3067\u8a55\u4fa1\u3067\u304d\u308b\u304b<\/p>\n<h4>\u4f0a\u52e2\u5d0e\u8840\u7ba1\u30e9\u30dc\u7814\u7a76\u4f1a\u201818\u30002018.10.1\uff08\u4f0a\u52e2\u5d0e\uff09<\/h4>\n<p>\u795e\u5c71\u5b8f<br \/>\n\u5f53\u30af\u30ea\u30cb\u30c3\u30af\u306b\u304a\u3051\u308b\u6297\u51dd\u56fa\u7642\u6cd5\u306e\u51fa\u8840\u7ba1\u7406\u306b\u3064\u3044\u3066<\/p>\n<h4>Diabetes &#038; Cardiovascular Interactive Webinar\uff5eTotal Management for CAD patients\uff5e\u30002018.10.2\uff08\u9ad8\u5d0e\uff09<\/h4>\n<p>\u5009\u6797\u6b63\u5f66<br \/>\n\u7a4d\u6975\u7684LDL-C\u4f4e\u4e0b\u7642\u6cd5\u306e\u65b0\u6642\u4ee3 <\/p>\n<h4>\u7b2c37\u56de\u81e8\u5e8a\u753b\u50cf\u8a3a\u65ad\u61c7\u8a71\u4f1a\u30002018.10.2\uff08\u524d\u6a4b\uff09<\/h4>\n<p>\u5c0f\u5c71\u6075\u5b50<br \/>\n\u5faa\u74b0\u5668\u9818\u57df\u306eFDG-PET\u691c\u67fb\u306b\u3064\u3044\u3066<\/p>\n<h4>\u7b2c247\u56de\u4e00\u822c\u5b9a\u671f\u5065\u5eb7\u8a3a\u65ad\u306b\u304a\u3051\u308b\u80f8\u90e8\u30ec\u30f3\u30c8\u30b2\u30f3\u5199\u771f\u306e\u8aad\u5f71\u8b1b\u5ea7\u30002018.10.13\uff08\u9ad8\u5d0e\uff09<\/h4>\n<p>\u8302\u6728\u3000\u5145<\/p>\n<h4>\u7b2c5\u56de\u5faa\u74b0\u5668\u30ec\u30af\u30c1\u30e3\u30fc\u30002018.10.15(\u524d\u6a4b\uff09<\/h4>\n<p>\u571f\u4e95\u5b8f<br \/>\nPCI\u5f8c\u306e\u8102\u8cea\u7ba1\u7406\uff5e\u201dChoosing Wisely\u201d\u306e\u8996\u70b9\u304b\u3089\u8003\u5bdf\u3059\u308b\uff5e<\/p>\n<h4>\u7b2c7\u56deGunma Prevent\u30002018.10.17\uff08\u524d\u6a4b\uff09<\/h4>\n<p>\u4f34\u91ce\u6f64\u4e00<br \/>\n\u7cd6\u5c3f\u75c5\u3092\u5408\u4f75\u3057\u305f\u5fc3\u75be\u60a3\u60a3\u8005\u306e\u904b\u52d5\u7642\u6cd5\u306b\u3064\u3044\u3066<\/p>\n<h4>\u5fc3\u8840\u7ba1\u7cd6\u5c3f\u75c5Conference\u30002018.10.22\uff08\u524d\u6a4b\uff09<\/h4>\n<p>\u5009\u6797\u6b63\u5f66<br \/>\n\u3053\u308c\u307e\u3067\u306e\u5927\u898f\u6a21\u81e8\u5e8a\u8a66\u9a13\u7d50\u679c\u304b\u3089\u307f\u305f\u7d4c\u53e3\u8840\u7cd6\u964d\u4e0b\u85ac\u306e\u8ab2\u984c<\/p>\n<h4>Crdio Diabetes Seminar\u30002018.10.26\uff08\u524d\u6a4b\uff09<\/h4>\n<p>\u7b20\u9593\u5468<br \/>\n2\u578b\u7cd6\u5c3f\u75c5\u5408\u4f75\u5fc3\u4e0d\u5168\u6cbb\u7642\u306b\u304a\u3051\u308b\u6cbb\u7642\u6226\u7565<\/p>\n<h4>\u7b2c248\u56de\u4e00\u822c\u5b9a\u671f\u5065\u5eb7\u8a3a\u65ad\u306b\u304a\u3051\u308b\u80f8\u90e8\u30ec\u30f3\u30c8\u30b2\u30f3\u5199\u771f\u306e\u8aad\u5f71\u8b1b\u5ea7\u30002018.11.15\uff08\u9ad8\u5d0e\uff09<\/h4>\n<p>\u8302\u6728\u3000\u5145<br \/>\n\u80ba\u7d50\u6838\u3000\u6700\u8fd1\u306e\u52d5\u5411\u3068\u753b\u50cf\u8a3a\u65ad<\/p>\n<h4>\u7cd6\u5c3f\u75c5\u5b66\u8853\u8b1b\u6f14\u4f1a\uff5e\u5fc3\u814e\u9023\u95a2\u3078\u306e\u30a2\u30d7\u30ed\u30fc\u30c1\uff5e\u30002018.11.19\uff08\u65b0\u6f5f\uff09<\/h4>\n<p>\u5009\u6797\u6b63\u5f66<br \/>\n\u30a8\u30d3\u30c7\u30f3\u30b9\u306b\u5b66\u3076\u7cd6\u5c3f\u75c5\u306e\u5fc3\u8840\u7ba1\u5408\u4f75\u75c7\u306e\u30e1\u30ab\u30cb\u30ba\u30e0\u3068\u6cbb\u7642\u6226\u7565<\/p>\n<h4>\u7b2c53\u56de\u57fc\u7389\u4e0d\u6574\u8108\u30da\u30fc\u30b7\u30f3\u30b0\u7814\u7a76\u4f1a\u30002018.11.24\uff08\u3055\u3044\u305f\u307e\uff09<\/h4>\n<p>\u6751\u4e0a\u6587\u5d07\u3001\u91d1\u53e4\u5584\u660e\u3001\u4e2d\u5cf6  \u5fe0\u3001\u98ef\u585a\u8cb4\u58eb\u3001\u7530\u6751\u5cfb\u592a\u90de\u3001\u9577\u8c37\u5ddd  \u5bdb\u3001\u5009\u6797\u6b63\u5f66<br \/>\nPseudo V-A-V\u53cd\u5fdc\u304b\u3089\u8a98\u767a\u3055\u308c\u305f\u4e09\u5c16\u5f01\u8f2a\u8d77\u6e90ATP\u611f\u53d7\u6027\u5fc3\u623f\u983b\u62cd\u306e\u4e00\u4f8b\uff0e <\/p>\n<h4>Scientific Excange Meeting\uff5e\u7cd6\u5c3f\u75c5\u6cbb\u7642\u306e\u30d1\u30e9\u30c0\u30a4\u30e0\u30b7\u30d5\u30c8\u3092\u8003\u3048\u308b\uff5e2018.11.26(\u524d\u6a4b\uff09<\/h4>\n<p>\u5009\u6797\u6b63\u5f66<br \/>\n\u5faa\u74b0\u5668\u533b\u304c\u8003\u3048\u308b\u7cd6\u5c3f\u75c5\u6cbb\u7642\u306e\u30d1\u30e9\u30c0\u30a4\u30e0\u30b7\u30d5\u30c8<\/p>\n<h4>\u7b2c7\u56deCirculation Frontier in Gunma\u30002018.11.30\uff08\u524d\u6a4b\uff09<\/h4>\n<p>\u52a0\u85e4\u5bff\u5149<br \/>\n\u4e9c\u6025\u6027\u306e\u7d4c\u904e\u3067\u591a\u767a\u6027\u8133\u6897\u585e\u3092\u767a\u75c7\u3057\u305fLibman Sacks\u5fc3\u5185\u819c\u708e\u306e\u4e00\u4f8b<\/p>\n<h4>\u7b2c21\u56de\u5fc3\u4e16\u4ee3\u6838\u533b\u5b66\u7814\u7a76\u4f1a 2018.12.1(\u6771\u4eac\uff09<\/h4>\n<p>\u3010\u4e00\u822c\u6f14\u984c\u3011\u5ea7\u9577\uff1a\u4e2d\u91cc\u826f\u5148\u751f\uff08\u8056\u8def\u52a0\u56fd\u969b\u75c5\u9662\u5faa\u74b0\u5668\u5185\u79d1\uff09<br \/>\n\u77f3\u6a4b\u6d0b\u5e73<br \/>\n\u6162\u6027\u5fc3\u4e0d\u5168\u60a3\u8005\u306b\u304a\u3051\u308bsmartMIBG-HF\u30bd\u30d5\u30c8\u30a6\u30a7\u30a2\u306b\u3088\u308b\u4e88\u5f8c\u4e88\u6e2c\u306e\u6709\u7528\u6027<\/p>\n<h4>CV&#038;Diabetes2018\u9ad8\u5d0e 2018.12.4\uff08\u9ad8\u5d0e\uff09<\/h4>\n<p>\u5009\u6797\u6b63\u5f66<br \/>\n\u7cd6\u5c3f\u75c5\u306e\u5fc3\u8840\u7ba1\u5408\u4f75\u75c7\u306e\u6210\u56e0\u3068\u4e88\u9632<\/p>\n<h4>NSCLC\u304c\u3093\u514d\u75ab\u7642\u6cd5\u30bb\u30df\u30ca\u30fcin\u4e2d\u6bdb\u5730\u533a :2018.12.6(\u524d\u6a4b\uff09<\/h4>\n<p>\u30d1\u30cd\u30eb\u30c7\u30a3\u30b9\u30ab\u30c3\u30b7\u30e7\u30f3<br \/>\n\u5317\u539f\u4fe1\u4ecb<br \/>\n\u7af9\u6751\u4ec1\u7537<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u7b2c17\u56de\u5317\u95a2\u6771\u5fc3\u8840\u7ba1\u5185\u5206\u6cccResearch Meeting\u30002018.1.12\uff08\u6771\u4eac\uff09 \u78ef\u3000\u9054\u4e5f\u3001Yogi Umbawaran,Mas Rizky Syamsunaruno\u3001\u5c0f\u677f\u6a4b\u7d00\u901a\u3001\u9808\u6c38\u6d69\u7ae0\u3001\u5009\u6797\u6b63\u5f66\u3001\u677e\u4e95\u5f18\u6a39 \u8ca0\u8377 [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":313,"menu_order":56,"comment_status":"closed","ping_status":"closed","template":"tpl_results.php","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-315","page","type-page","status-publish","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/gucvmed.med.gunma-u.ac.jp\/index.php?rest_route=\/wp\/v2\/pages\/315","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/gucvmed.med.gunma-u.ac.jp\/index.php?rest_route=\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/gucvmed.med.gunma-u.ac.jp\/index.php?rest_route=\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/gucvmed.med.gunma-u.ac.jp\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/gucvmed.med.gunma-u.ac.jp\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=315"}],"version-history":[{"count":1,"href":"https:\/\/gucvmed.med.gunma-u.ac.jp\/index.php?rest_route=\/wp\/v2\/pages\/315\/revisions"}],"predecessor-version":[{"id":316,"href":"https:\/\/gucvmed.med.gunma-u.ac.jp\/index.php?rest_route=\/wp\/v2\/pages\/315\/revisions\/316"}],"up":[{"embeddable":true,"href":"https:\/\/gucvmed.med.gunma-u.ac.jp\/index.php?rest_route=\/wp\/v2\/pages\/313"}],"wp:attachment":[{"href":"https:\/\/gucvmed.med.gunma-u.ac.jp\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=315"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}